About Baptist Medical Center
|
|
- Myra Perkins
- 6 years ago
- Views:
Transcription
1
2 About Baptist Medical Center Locally owned and operated in Jacksonville, Florida BMC includes 2 Adult and 1 Children s Hospital 960 licensed beds Disproportionate Share Hospital Recently opened Baptist MD Anderson Cancer Center Added 3 Remote Emergency Rooms
3 About 340B U.S. federal government program Created in 1992 Requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities that care for indigent patients at significantly reduced prices
4 Program Intent The Congressional intent of the program is to allow covered entities to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services
5 340B Hospital Eligibility The following hospital entity types must meet eligibility criteria to be included in the 340B Drug Pricing Program: Disproportionate Share Hospital (DSH)¹ Children s Hospital (PED)¹ Free-Standing Cancer Hospital (CAN)¹ Critical Access Hospital (CAH) Rural Referral Center (RRC) Sole Community Hospital (SCH) 1 Requirement includes Nonprofit/Government Contract & DSH percentage >11.75%
6 340B Hospital Eligibility To participate in the 340B program covered entities must register, be enrolled, and comply with the following requirements: Covered Entity eligibility (parent & child sites) Patient definition Contract Pharmacy Compliance Covered entities must complete the recertification process every year.
7 340B Hospital Clinic Eligibility To purchase 340B drugs, a hospital outpatient clinic must: Be an integral part of the 340B eligible hospital Appear as a reimbursable clinic above line 90 on Worksheet A of the hospital s most recently filed Medicare cost report Have patients that meet the criteria in the 340B patient definition guideline Submit to HRSA the most recently filed cost report to verify clinic eligibility Be listed on the HRSA 340B Database as an eligible parent or child site
8 340B Patient Definition Only patients that meet the following criteria are eligible for 340B purchased drugs 1. The covered entity has established a relationship with the individual, such that the covered entity maintains records of the individual s health care. 2. The individual receives health care services from a health care professional who is either employed by the covered entity or provides health care under contractual or other arrangements (e.g., referral for consultation) such that responsibility for the care provided remains with the covered entity. 3. The individual s drug is ordered or prescribed pursuant to a health care service that is classified as outpatient.
9 340B Contract Pharmacy 340B covered entities may contract with a pharmacy (or pharmacies) to provide pharmacy services to the covered entity s patients. Registered with HRSA and listed on the 340B HRSA database Written and signed contract pharmacy services agreement to include the dispensing fees and operational procedures Bill to/ Ship to account for purchasing drugs Policy and procedures in place to determine patient eligibility, methods for preventing diversion and duplicate discounts, and maintenance of auditable records.
10 340B Compliance Elements Prevention of Diversion Covered Entities are responsible for maintaining an accurate patient eligibility determination system, including tracking and accounting of all 340B drugs at the covered entity to ensure diversion has not occurred. Prevention of Duplicate Discounts A duplicate discount, prohibited by the 340B statute, occurs when manufacturers both provide a 340B discount on a drug AND pay a Medicaid rebate to the state on the same drug. A duplicate discount would occur if an up-front 340B discount is given and the state submits the same claim for a back-end Medicaid rebate. 340B covered entities are prohibited from causing a duplicate discount to occur. The Covered Entity must attest that they will carve-in or carve-out for Medicaid FFS to prevent duplicate discounts. GPO Prohibition A hospital subject to the GPO Prohibition may not purchase covered outpatient drugs through a GPO or GPO-like arrangement for any of its clinics or departments within the four walls of the hospital (at the same physical address) or its offsite outpatient clinics that are participating in the 340B Program and registered on the HRSA 340B Database.
11 340B Pricing
12 Program Savings Hospital Outpatients Drug Purchases Covered Entities realize significant savings for drugs used in the outpatient areas of the Hospital from the difference between the GPO vs. the 340B drug cost. Contract Retail Pharmacy(ies) Covered Entities may have one or more contracts with local retail pharmacies throughout their service area, where the Contract Pharmacy adjudicates & dispenses the prescriptions of Hospital s patients. On a monthly basis, the pharmacy retains a dispensing fee while the Covered Entity receives the revenue from the Third Party & patient copay and purchases the drugs at the 340B cost, which then is shipped to the dispensing pharmacy. Contract Specialty Pharmacy(ies) Specialty pharmacies receive far fewer prescriptions from the patients of the covered entity and are often located in different areas of the state/country. In addition, insurance restrictions and/or limited distribution of the drugs often dictate where the Rx can be filled. However, the high cost and potential savings from these Rx, as well as the added service to assist these patients to promptly get their drugs make this an important service for the Hospital to provide.
13 About Ponaman Phoenix based consulting firm established in 2001 Focused solely on 340B Serves clients in 43 states and Puerto Rico o Hospitals o HRSA grantees Has participated in over 50 HRSA audits
14 Current 340B Landscape 340B is front and center in drug pricing debate New Leadership Cuts to Part B Reimbursement Bills introduced in House and Senate
15 HHS Secretary Alex Azar Former executive at Eli Lilly Formerly served as General Counsel and Deputy Director of HHS under George W. Bush
16 Part B Payment Cuts Final rule went into effect on Jan. 1, B Hospitals (excluding CAHs) must use modifiers when billing for Part B drugs o DSH and RRCs will received reduced reimbursements rates for these items o New rate is ASP minus 22.5% Rep. McKinley (R-W.Va.) and Rep. Thompson (D-Ca.) have introduced a bill to prevent the cuts from being implemented Hospital associations and several hospitals filed a lawsuit against CMS in an attempt to stop implementation o The suit was dismissed due to it being filed prior to the rule s implementation o The hospital groups are appealing the decision and have asked the appeals court for an expedited review o Oral arguments possible as soon as April
17 Energy & Commerce Committee Report Released on January 10, 2018 Recommendations include regulatory and legislative changes to program Re-evaluate program intent Review and update DSH eligibility requirements Create strict reporting requirements for hospitals on use of program savings Initially noted that recommendations would be addressed by the end of March
18 340B PAUSE Act H.R Introduced in the House by Reps. Bucshon (R-IN) and Peters (D- CA) Recommends 2 year freeze on DSH enrollment in 340B Requires strict reporting for hospitals on program savings Calls for additional GAO and OIG reports
19 340B HELP Act S Introduced in the Senate by Sen. Cassidy (R-LA) Would implement 2 year freeze on DSH enrollment in 340B New eligibility requirements for DSH, children s, and cancer hospitals Implements sliding fee scale requirements for hospitals Adds new 340B modifiers Calls for additional GAO and OIG reports
20 White House Advisory Report The report outlines program changes that could be made to address the high cost of drugs including: Limiting 340B drug reimbursement to cover the "uses the purchased drugs are intended to treat. Only providing 340B drugs to the intended poor patient populations. Developing more precise eligibility criteria [to] help meet the primary goals of the program in the future. Allowing a single agency to set prices at which the eligible providers can buy drugs. There is skepticism in the Congress around how limiting 340B would help lower drug costs
21 President s Budget 340B mentioned in President s proposed budget Proposes broad regulatory authority for the 340B program to set enforceable standards of program participation and require all covered entities to report on use of program savings. Recommends new 340B User Fee This was included in former President Obama s budget but was never implemented
22 Thinking Strategically about 340B With all the attention on the program right now, compliance central to maintaining the integrity of the program HRSA is ramping up its audits of 340B Programs Internal monitoring Regular external auditing Regular meetings with key internal stakeholders Policies and Procedures
23 Best Practices for Running a Compliant Program Develop an oversight committee with key stakeholders for 340B Include finance, IT, pharmacy, etc. Set and establish appropriate expectations for staff Hold regular meetings to review and analyze 340B data Research and resolve issues as they come up Disclose any issues to HRSA or manufactures as soon as they arise
24 Conduct Regular Internal Audits Mixed-use Settings ED, Infusion Center, etc. In-house and Contract/Retail Pharmacy Provider and patient eligibility Referrals Discharge patients Physician-administered Medications
25 Recommended External Audits HRSA recommends having an annual independent external audit of contract pharmacy/ies Recommended annual split-billing audits Validate eligibility processing practices
26 Avoid Common Pitfalls Lack of internal oversight Loss of knowledge during staff turnover Changing expectations of 340B Program Vendor relationships
27 Questions? Chris R. Durkin, FHFMA Vice President /Controller Baptist Health (904) Scott Ponaman President Ponaman Healthcare Consulting (480)
340B Compliance. Overview
340B Compliance LIFE AFTER A HRSA AUDIT AND IMPLEMENTING A CORRECTIVE ACTION PLAN HCCA Compliance Institute March 27, 2017 Presented by: Melissa Singleton Sarah Bowman, CHC Overview 340B Program Background
More information340B Drug Program Summary
Summary Congress created section 340B of the Public Health Service Act in 1992 to allow eligible health care providers known as Covered Entities to stretch scarce Federal resources, reaching more patients
More informationIntroduction to 340B Part 1 of 2 February 5, 2014
Introduction to 340B Part 1 of 2 February 5, 2014 Lisa Scholz, PharmD, MBA Chief Operating Officer/Chief Pharmacy Officer Safety Net Hospitals for Pharmaceutical Access 10 th Annual 340B Winter Conference
More information340B Program Overview
340B Program Overview OSHP 77 th Annual Meeting Friday, April 22, 2016 Kevin Williams PharmD Candidate 2016 University of Cincinnati James L. Winkle College of Pharmacy Katie McKinney, PharmD, MS, BCPS
More information340B Program Mgr Vice President, Finance SVP, Chief Audit, Ethics & Compliance Officer
340B Drug Purchasing Program Page 1 of 7 340B Drug Purchasing Program Policy & Procedure Number Policy Manual Ethics and Compliance Type Policy & Procedure Document Owner Effective Date Next Review Date
More information340B DRUG PRICING PROGRAM
340B DRUG PRICING PROGRAM Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy Pro Pharma Pharmaceutical Consultants, Inc. Under the preceptorship of Dr. Craig Stern
More informationAREAS OF RESPONSIBILITY
Applies To: UNMH and UNMCC Responsible Department: Pharmacy Revised: 5/1/2016 Guideline Patient Age Group: (x) N/A ( ) All Ages ( ) Newborns ( ) Pediatric ( ) Adult DESCRIPTION/OVERVIEW This document contains
More informationDESCRIPTION/OVERVIEW This document contains descriptions of the procedures used at UNM Hospital to maintain compliance with the 340B Program.
Applies To: UNMH, UNMCC Responsible Department: Pharmacy Revised: 10/2014 Guideline Patient Age Group: (X ) N/A ( ) All Ages ( ) Newborns ( ) Pediatric ( ) Adult DESCRIPTION/OVERVIEW This document contains
More informationbeyond the pharmacy Common 340B program concerns for hospitals Making sure expectations meet reality March 13, 2015
beyond the pharmacy Common 340B program concerns for hospitals Making sure expectations meet reality March 13, 2015 Lidia A. Rodriguez-Hupp SVP & 340B Compliance Officer Christopher Boles Regional VP,
More informationTaking Into Account Entire Supply Chain. Biopharmaceutical Companies
340B 101 Taking Into Account Entire Supply Chain Biopharmaceutical Companies Providers Payers and PBMs 2 Medicine Spending is in Line with Other Health Care Services Percent Annual Growth Rate Health Care
More informationOverview of the Federal 340B Drug Pricing Program
Overview of the Federal 340B Drug Pricing Program Presented by: James A. Raley, CPA Senior Manager Health Care Services Arnett Carbis Toothman LLP 345 340B Program: Overview Provides discounts on outpatient
More information340B DRUG PRICING PROGRAM: 2016 EXPECTED UPDATES
340B DRUG PRICING PROGRAM: 2016 EXPECTED UPDATES P R E S E N T E D B Y : T H U Y L E, U S C S C H O O L O F P H A R M A C Y, C A N D I D A T E O F 2 0 1 7 P R E C E P T O R : C R A I G S T E R N, P H A
More informationObjectives. 340B Implementation and Audit Preparation. Section 340B of the Public Health Services Act of Disclaimer. MFR Agreement with 340B
340B Implementation and Audit Preparation Mike Loftus, RPh Assistant Director of Pharmacy Mercy Hospital Springfield 340B Program Administrator for Mercy Health System The speaker has no conflict of interest
More information340 Program Compliance 2018 MICHIGAN FAMILY PLANNING UPDATE
340 Program Compliance 2018 MICHIGAN FAMILY PLANNING UPDATE 1 The 4-1-1 on 340B ENACTMENT Passed as part of Veteran s Health Care Act of 1992 to provide discounts on outpatient drugs to certain provider
More informationAssociation of Cancer Executives
Association of Cancer Executives 340B Drug Pricing Program How to Get It and Make the Most of It January 31, 2014 ECG Management Consultants, Inc. Our mission is to provide exceptional management consulting
More informationUpdate on 340B Drug Pricing Program
Update on 340B Drug Pricing Program LCDR Joshua E. Hardin MBA, RN/BSN, MLT Donna Murray Office of Pharmacy Affairs U.S. Department of Health and Human Services Health Resources and Services Administration
More informationJeremiah McWilliams, PharmD
Jessica Blackburn Vice President, 340B Advisors, LLC Attorney, Pointer Law Office, P.C. Jeremiah McWilliams, PharmD Senior Director, 340B Account Services Wellpartner, Inc HRSA Audits began 2012 Total
More informationHRSA Audit Findings and Implications for Patient Definition
HRSA Audit Findings and Implications for Patient Definition August 20, 2015 Speakers: Maureen Testoni Senior Vice President and General Counsel Jeff Davis Counsel, Legal and Policy Affairs 2015 340B Health
More informationDobson DaVanzo & Associates, LLC Vienna, VA
Analysis of Patient Characteristics among Medicare Recipients of Separately Billable Part B Drugs from 340B DSH Hospitals and Non-340B Hospitals and Physician Offices Dobson DaVanzo & Associates, LLC Vienna,
More informationFederal Regulatory Policy Report. NACHC Study: Benefits of the 340B Drug Pricing Program for Health Centers
Federal Regulatory Policy Report NACHC Study: Benefits of the 340B Drug Pricing Program for Health Centers May 2011 NACHC Study on the Benefits of the 340B Drug Pricing Program for Health Centers May 2011
More information340B Compliance in an Era of Increased Oversight
340B Compliance in an Era of Increased Oversight Bill von Oehsen President/General Counsel Maureen Assistant General Counsel Wednesday, January 25, 2012 1:00-2:30 PM (Eastern Time) Phone: (800) 895-0231
More informationDecember 21, 2012 BY ELECTRONIC DELIVERY
BY ELECTRONIC DELIVERY CDR Krista M. Pedley, PharmD, MS, USPHS Director Office of Pharmacy Affairs Healthcare Systems Bureau Health Resources and Services Administration 5600 Fishers Lane Parklawn Building,
More informationomnibus guidance Reviewing six key points October 19, 2015 Lidia A. Rodriguez-Hupp SVP & 340B Compliance Officer
omnibus guidance Reviewing six key points October 19, 2015 Lidia A. Rodriguez-Hupp SVP & 340B Compliance Officer Dawn C. DeAngelo Chief Pharmacy Officer today s presenters Lidia A. Rodriguez-Hupp 340B
More informationCurrent Trends in the 340B Drug Pricing Program. November 8, 2011
Current Trends in the 340B Drug Pricing Program November 8, 2011 Housekeeping Welcome to our webinar on the HRSA s 340B Program Below are some webinar housekeeping items: Kick-off polling question. Please
More informationOverview of Select Health Provisions FY 2015 Administration Budget Proposal
Overview of Select Health Provisions FY 2015 Administration Budget Proposal On March 4, 2014, President Obama released his Administration s FY 2015 budget proposal to Congress. The budget contains a number
More informationExecutive Summary BERKELEY RESEARCH GROUP COMPLIANCE TRENDS WITH HOSPITAL CHARITY CARE REQUIREMENTS
Executive Summary Study Background: The Affordable Care Act (ACA) established new requirements for 501(c)(3) hospitals pertaining to their charity care policies. Hospitals self-report data related to these
More informationNeedyMeds
NeedyMeds www.needymeds.org Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.
More informationhttps://www.apexus.com/solutions/education/340b-u-ondemand
APPENDIX SIX: SELF-AUDIT TOOLS This appendix contains tools that may be used by a health center in testing its compliance with the 340B Program guidelines. In addition to the checklists and audit guidance
More information340B Program Tool Kit
340B Program Tool Kit June 2014 7501 Wisconsin Avenue Suite 1100W Bethesda, MD 20814 Phone 301.347.0400 Fax 301.347.0459 www.nachc.com 9 Carey Road Queensbury, NY 12804 (855) 835-340B www.340bsolutions.org
More informationpaymentbasics The IPPS payment rates are intended to cover the costs that reasonably efficient providers would incur in furnishing highquality
Hospital ACUTE inpatient services system basics Revised: October 2015 This document does not reflect proposed legislation or regulatory actions. 425 I Street, NW Suite 701 Washington, DC 20001 ph: 202-220-3700
More informationPhysician Payments Disclosure and Aggregate Spend:
Physician Payments Disclosure and Aggregate Spend: Navigating Conflicting and Unclear State Laws and Regulations A Guide for Device Manufacturers October 26, 2010 Colin J. Zick Foley Hoag LLP czick@foleyhoag.com
More informationMay 3, 2018 Rick Reid Director, Provider Payment Analytics Michael Felczak Director, Provider Payment Analytics
Hot Reimbursement Topics Rural Area Hospitals May 3, 2018 Rick Reid Director, Provider Payment Analytics Michael Felczak Director, Provider Payment Analytics RICHARD S. REID, MPA, FHFMA, CPA, Director,
More informationAnalysis of 340B Disproportionate Share Hospital Services to Low- Income Patients
Analysis of 340B Disproportionate Share Hospital Services to Low- Income Patients March 12, 2018 Prepared for: 340B Health Prepared by: L&M Policy Research, LLC 1743 Connecticut Ave NW, Suite 200 Washington,
More informationpaymentbasics Defining the inpatient acute care products Medicare buys Under the IPPS, Medicare sets perdischarge
Hospital ACUTE inpatient services system basics Revised: October 2007 This document does not reflect proposed legislation or regulatory actions. 601 New Jersey Ave., NW Suite 9000 Washington, DC 20001
More informationRe: California Health+ Advocates opposes the proposed state budget changes to the 340B program
May 2, 2017 René Mollow, Deputy Director Health Care Benefits and Eligibility Department of Health Care Services 1501 Capitol Avenues, MS 0007 P.O. Box 997413 Sacramento, CA 95899-7413 Re: California Health+
More informationPatient Section. Patient Name: (Last) (First) (MI) Address: City: State: Zip: Date of Birth: / / Month Day Year Home Phone: ( ) - Cell Phone: ( ) -
Lilly Cares Foundation Patient Assistance Program PO Box 13185 La Jolla, CA 92039 1-800-545-6962 Fax: (844) 431-6650 www.lillycares.com Patient Name: (Last) (First) (MI) Address: City: State: Zip: Date
More informationProvider Based Status Compliance: Space Sharing and Reimbursement Charges
Provider Based Status Compliance: Space Sharing and Reimbursement Charges Presentation by Karen Smith 614.227.2313 ksmith@bricker.com Claire Turcotte 513.870.6573 cturcotte@bricker.com Bricker & Eckler
More informationEVALUATING 340B HOSPITAL SAVINGS AND THEIR USE IN SERVING LOW-INCOME AND RURAL PATIENTS
EVALUATING 340B HOSPITAL SAVINGS AND THEIR USE IN SERVING LOW-INCOME AND RURAL PATIENTS Results from 340B Health s 2017 Annual Survey Savings from participating in the 340B drug pricing program are critical
More informationSubtitle E New Options for States to Provide Long-Term Services and Supports
LONG TERM CARE (SECTION-BY-SECTION ANALYSIS) (Information compiled from the Democratic Policy Committee (DPC) Report on The Patient Protection and Affordable Care Act and the Health Care and Education
More informationPatient Section All fields are required. Please print clearly and complete all information.
Lilly Cares Foundation Patient Assistance Program PO Box 13185 La Jolla, CA 92039 Phone: 1-800-545-6962 Fax: 1-844-431-6650 www.lillycares.com Patient Section All fields are required. Please print clearly
More informationUpdate to a 2012 Analysis of 340B Disproportionate Share Hospital Services Delivered to Vulnerable Patient Populations
Update to a 2012 Analysis of 340B Disproportionate Share Hospital Services Delivered to Vulnerable Patient Populations Eligibility Criteria for 340B DSH Continue to Appropriately Target Safety Net Dobson
More informationHRSA 19 Program Requirements Recommendations to satisfy 340B, HRSA & FTCA
HRSA 19 Program Requirements Recommendations to satisfy 340B, HRSA & FTCA The measures listed below are the 19 Program Requirements for HRSA Grantees The following actions will best satisfy 340B The following
More informationLegal Update. Michael B. Glomb, Partner Marisa Guevara, Associate Elizabeth Issie Karan, Associate September 22, 2015
Legal Update Michael B. Glomb, Partner Marisa Guevara, Associate Elizabeth Issie Karan, Associate September 22, 2015 LEGAL DISCLAIMER This presentation is educational in nature and does not constitute
More informationNicole N. Crase Pharmacy Manager/340B Peer to Peer Mentor Five Rivers Health Centers
Nicole N. Crase Pharmacy Manager/340B Peer to Peer Mentor Five Rivers Health Centers Statement of Conflict of Interest Nicole Crase has no actual or potential conflict of interest in relation to this presentation
More informationHEALTH LAW PERSPECTIVES
Celebrating 20 YEARS of excellence HEALTH LAW PERSPECTIVES Newsletter Volume 11, No. 3 March 2009 Medi-Cal Providers Must Begin Billing With National Drug Codes: Medi-Cal Will Start Denying Claims Without
More informationRural Provider Types and Payment Models
Rural Provider Types and Payment Models Emily Jane Cook, JD, MSPH McDermott Will & Emery LLP American Health Lawyers Association Institute on Medicare and Medicaid Payment Issues Baltimore, MD March 28,
More informationMISSION STATEMENT The mission of the SVHCD is to maintain, improve, and restore the health of everyone in our community.
SVHCD QUALITY COMMITTEE AGENDA WEDNESDAY, FEBRUARY 28, 2018 5:00 p.m. Regular Session (Closed Session will be held upon adjournment of the Regular Session) Location: Schantz Conference Room Sonoma Valley
More informationMaintaining 340B Program Compliance
Maintaining 340B Program Compliance Tuesday, June 24, 2014 3:30 4:45 PM Ted Slafsky, President & Chief Executive Officer Safety Net Hospitals for Pharmaceutical Access Maureen Testoni, General Counsel
More informationExhibit A GENERAL INFORMATION
GENERAL INFORMATION A. Eligibility 1. What are the criteria for eligibility? Eligibility falls under Rule 64D-4 Florida Administrative Code. Criteria for core eligibility is Proof of HIV, Proof of Living
More informationLong Term Care Group Services Organizations Not Just for Nursing Home Providers Anymore
Long Term Care Group Services Organizations Not Just for Nursing Home Providers Anymore Presented by: Denny Sherrill, Vice President, GeriMed John Schutte, President, GeriMed 2:15 p.m. - 3:45 p.m., Tuesday,
More information340B Savings Equal Improved Patient Care
340B Savings Equal Improved Patient Care Lisa Scholz, PharmD, MBA Chief Operating Officer/Chief Pharmacy Officer Safety Net Hospitals for Pharmaceutical Access 10 th Annual 340B Coalition Winter Conference
More informationCORPORATE COMPLIANCE POLICY AUDIT & CROSSWALK WHERE ADDRESSED
QUALITY OF CARE Sufficient Staffing Inadequate staffing levels or insufficiently trained (inadequate clinical expertise) or insufficiently supervised staff providing medical, nursing, and related services
More informationProvider-Based Status, Under Arrangements, and Related Medicare Requirements
Provider-Based Status, Under Arrangements, and Related Medicare Requirements AHLA Medicare & Medicaid Law Institute Baltimore, MD March 26, 2015 Andrew Ruskin Lawrence Vernaglia Morgan Lewis & Bockius
More informationELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES
ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES Introduction The competency areas, goals, and objectives are for use with the ASHP Accreditation Standard
More informationACO REVIVAL. Medicare Shared Savings Program Final Regulation Overview. Blue & Co., LLC Healthcare Reform Symposium Thursday, November 3, 2011
ACO REVIVAL Medicare Shared Savings Program Final Regulation Overview Blue & Co., LLC Healthcare Reform Symposium Thursday, November 3, 2011 11/03/2011 1 Introductions John Redding, MD, MBA Manager Healthcare
More informationReimbursement Models of the Future A Look at Proposed Models
Experience the Eide Bailly Difference Reimbursement Models of the Future A Look at Proposed Models Ralph J. Llewellyn, CPA, CHFP Partner rllewellyn@eidebailly.com 701.239.8594 Introduction CAH reimbursement
More informationOverview of the EHR Incentive Program Stage 2 Final Rule published August, 2012
I. Executive Summary and Overview (Pre-Publication Page 12) A. Executive Summary (Page 12) 1. Purpose of Regulatory Action (Page 12) a. Need for the Regulatory Action (Page 12) b. Legal Authority for the
More informationPharmacy Compliance: Beyond Med Errors. Overview
Pharmacy Compliance: Beyond Med Errors Daniel P. Fitzgerald, Senior Attorney Litigation & Regulatory Law Department Walgreen Co. James S. Mathis, Esq., Nashville, TN Overview Med Errors & Controlled Substances
More informationHealth Care Reform Provisions Affecting Older Adults and Persons with Special Needs 3/30/10
Health Care Reform Provisions Affecting Older Adults and Persons with Special Needs 3/30/10 On March 23, 2010, President Obama signed a comprehensive health care reform bill (H.R. 3590) into law. On March
More informationPayment: We are permitted to use and disclose your health information to receive payment for our services. For example, we may:
Your Rx Pharmacy Notice of our privacy practices THIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationApril 8, 2013 RE: CMS 3267 P. Dear Administrator Tavenner,
April 8, 2013 Marilyn Tavenner, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS 3267 P P.O. Box 8010 Baltimore, MD 21244 8010 RE: CMS 3267
More informationTCS FAQ s. How will the implementation of national standard code sets reduce burden on the health care industry?
TCS FAQ s What is a code set? Under HIPAA, a code set is any set of codes used for encoding data elements, such as tables of terms, medical concepts, medical diagnosis codes, or medical procedure codes.
More informationManaging employees include: Organizational structures include: Note:
Nursing Home Transparency Provisions in the Patient Protection and Affordable Care Act Compiled by NCCNHR: The National Consumer Voice for Quality Long-Term Care, April 2010 Part I Improving Transparency
More informationState advocacy roadmap: Medicaid access monitoring review plans
State advocacy roadmap: Medicaid access monitoring review plans Background Federal Medicaid law requires states to ensure Medicaid beneficiaries are able to access the healthcare providers they need through
More informationPrescription Monitoring Program State Profiles - Illinois
Prescription Monitoring Program State Profiles - Illinois Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationHRSA S PROPOSED OMNIBUS GUIDANCE WOULD JEOPARDIZE 340B HOSPITALS: RESULTS FROM A SURVEY OF 340B HEALTH MEMBERS
HRSA S PROPOSED OMNIBUS GUIDANCE WOULD JEOPARDIZE 340B HOSPITALS: RESULTS FROM A SURVEY OF 340B HEALTH MEMBERS The Health Resources and Services Administration s 2015 proposed guidance on the 340B Drug
More informationDepartment of Health and Human Services. Centers for Medicare & Medicaid Services. Medicaid Integrity Program
Department of Health and Human Services Centers for Medicare & Medicaid Services Medicaid Integrity Program California Comprehensive Program Integrity Review Final Report Reviewers: Jeff Coady, Review
More informationREGULATION, ACCREDITATION, AND PAYMENT PRACTICE GROUP (June, July, August 2004)
REGULATION, ACCREDITATION, AND PAYMENT PRACTICE GROUP (June, July, August 2004) Lester J. Perling Broad and Cassel Fort Lauderdale, Florida I. Case Summaries CMNs Document Medical Necessity In Maximum
More informationHospice Program Integrity Recommendations
Hospice Program Integrity Recommendations Projected increases in the elderly population and the number of Medicare beneficiaries will likely result in continued growth in utilization of hospice services.
More informationManaged Medicaid Impact, Trends and Challenges. February 29, 2012 Las Vegas, NV
Managed Medicaid Impact, Trends and Challenges February 29, 2012 Las Vegas, NV Learning Objectives Recognize the impact of the Affordable Care Act on Managed Medicaid Contrast trends in Fee for Service
More informationCMS Ignored Congressional Intent in Implementing New Clinical Lab Payment System Under PAMA, ACLA Charges in Suit
FOR RELEASE Media Contacts: December 11, 2017 Erin Schmidt, (703) 548-0019 eschmidt@schmidtpa.com Rebecca Reid, (410) 212-3843 rreid@schmidtpa.com CMS Ignored Congressional Intent in Implementing New Clinical
More informationHospital Rate Setting
Hospital Rate Setting Calendar Year 2014 Wisconsin Department of Health Services Division of Health Care Access and Accountability Bureau of Fiscal Management September 6, 2013 1 Agenda 1. Introduction
More informationASTHO Increasing Access to Contraception Learning Community Virtual Learning Session #4
ASTHO Increasing Access to Contraception Learning Community Virtual Learning Session #4 June 6, 2017 2:00-4:00p ET For Audio: 866-740-1260, ext 7428625# Welcome and Introductions Welcome from ASTHO Christi
More informationMeaningful Use of EHR Technology:
Meaningful Use of EHR Technology: What Do the New Standards and Certification Criteria Mean for Your Organization? January 20, 2010 Mitchell J. Olejko Ropes & Gray LLP mitchell.olejko@ropesgray.com 415-315-6328
More informationTelemedicine Reimbursement. An Overview for Oregon
Telemedicine Reimbursement An Overview for Oregon A Brief History - Medicare In 1997 the Balanced Budget Act first authorized Medicare to reimburse for telemedicine services Since 2000 there have been
More informationPARITY IMPLEMENTATION COALITION
PARITY IMPLEMENTATION COALITION Frequently Asked Questions and Answers about MHPAEA Compliance These are some of the most commonly asked questions and answers by consumers and providers about their new
More informationPenn Specialty Pharmacy Program mypennpharmacy bringing the Pharmacy to Patients
Penn Specialty Pharmacy Program mypennpharmacy bringing the Pharmacy to Patients Richard F Demers, MS, RPh, FASHP Chief Administrative Officer Ambulatory Pharmacy Services University of Pennsylvania Health
More informationContingency Planning. Medicare Competitive Bidding. for. Mike Tootell Harvard Medical Device Congress March 29, 2007
Contingency Planning for Medicare Competitive Bidding Mike Tootell Harvard Medical Device Congress March 29, 2007 Necessary Disclaimer Speaking as individual Not representative of Abbott Laboratories Medicare
More information19/09/2017. Telehealth Legal and Regulatory Issues in Colorado and Beyond. Nathaniel Lacktman, October 2017
Telehealth Legal and Regulatory Issues in Colorado and Beyond Nathaniel Lacktman, Esq. @Lacktman October 2017 1 2 1 Licensing 3 Licensing Physician offering care via telemedicine is subject to licensure
More informationSelf-Referral, Markups, Fee Splitting, and Related Practices
Policy Statement Self-Referral, Markups, Fee Splitting, and Related Practices (Policy Number 04-03) Policy Statement ASCP strongly supports federal and state self-referral prohibitions, anti-markup requirements
More informationHCCA South Central Regional Annual Conference November 21, 2014 Nashville, TN. Post Acute Provider Specific Sections from OIG Work Plans
HCCA South Central Regional Annual Conference November 21, 2014 Nashville, TN Kelly Priegnitz # Chris Puri # Kim Looney Post Acute Provider Specific Sections from 2012-2015 OIG Work Plans I. NURSING HOMES
More informationManaged Care Fraud: Enforcement and Compliance HCCA Compliance Institute March 28, 2017
Managed Care Fraud: Enforcement and Compliance HCCA Compliance Institute March 28, 2017 Pamela Coyle Brecht, Partner Pietragallo Gordon Alfano Bosick & Raspanti, LLP Risk Area: False Data and/or Certifications
More informationPhysician Arrangement Integrity
Setup Tips Streamline Process Agreements Violation Risks Manage and Measure Physician Arrangement Integrity 1 HCCA Conference April 20, 2016 Agenda 1. Stark Law and Anti-kickback Statute 2. Lessons learned
More informationFAQ: Preferred pharmacy supplier changes for Specialty and Mail order medications
FAQ: Preferred pharmacy supplier changes for Specialty and Mail order medications Table of Contents BACKGROUND... 2 OVERALL TALKING POINTS... 2 GENERAL FAQ... 3 SPECIALTY MEDICATIONS... 5 MAIL ORDER...
More informationComparison of Health IT Provisions in H.R. 6 (21 st Century Cures Act) and S (Improving Health Information Technology Act)
Comparison of Health IT Provisions in H.R. 6 (21 st Century Cures Act) and S. 2511 (Improving Health Information Technology Act) Policy Proposal Health Software Regulation Senate Innovations Initiative
More informationSummary of U.S. Senate Finance Committee Health Reform Bill
Summary of U.S. Senate Finance Committee Health Reform Bill September 2009 The following is a summary of the major hospital and health system provisions included in the Finance Committee bill, the America
More informationCHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 202
CHAPTER 2016-30 Committee Substitute for Committee Substitute for Senate Bill No. 202 An act relating to the Florida Association of Centers for Independent Living; amending s. 413.402, F.S.; requiring
More informationWHICH PRESCRIPTIONS ARE 340B-ELIGIBLE
WHICH PRESCRIPTIONS ARE 340B-ELIGIBLE UPDATED MARCH 2018 A. General Information According to the 340B statute, FQHCs (and other covered entities) may only provide 340B purchased drugs to individuals who
More informationCritical Access Hospitals & Compliance Programs. Gregory N. Etzel, Esq. B. Scott McBride, Esq. Health Industry Group Vinson & Elkins LLP
Critical Access Hospitals & Compliance Programs Gregory N. Etzel, Esq. B. Scott McBride, Esq. Health Industry Group Vinson & Elkins LLP History and Background Critical Access Hospitals ( CAH )were established
More informationJohn W. Gahan Jr. Department of Health
John W. Gahan Jr. Department of Health Indigent Care Pool Electronic Health Record Medicaid Reimbursement FQHC s Other Clinics Appeals Meaningful Use Primary Medical Home General Billing 2010 AHCF-1 Questions
More informationImpact of Financial and Operational Interventions Funded by the Flex Program
Impact of Financial and Operational Interventions Funded by the Flex Program KEY FINDINGS Flex Monitoring Team Policy Brief #41 Rebecca Garr Whitaker, MSPH; George H. Pink, PhD; G. Mark Holmes, PhD University
More informationDivision C: Increasing Choice, Access, and Quality in Health Care for Americans TITLE XV: Provisions Relating to Medicare Part A
Division C: Increasing Choice, Access, and Quality in Health Care for Americans TITLE XV: Provisions Relating to Medicare Part A Sec. 15001. Development of Medicare study for HCPCS versions of MS-DRG codes
More informationRural Medicare Provider Types and Payment Provisions
Rural Medicare Provider Types and Payment Provisions American Health Lawyers Association Institute on Medicare and Medicaid Payment Issues March 25-27, 2015 Emily Jane Cook I. What is Rural?- Common Rural
More information(Cont.) FORM CMS Line 3--This is an institution which meets the requirements of 1861(e) or 1861(mm)(1) of the Act and participate
11-16 FORM CMS-2552-10 4004.1 4004. WORKSHEET S-2 - HOSPITAL AND HOSPITAL HEALTH CARE COMPLEX IDENTIFICATION DATA This worksheet consists of two parts: Part I - Hospital and Hospital Health Care Complex
More informationRevenue Optimization In Hospital Pharmacy Services. Presenters: Kyle Skiermont, PharmD, COO, Fairview Pharmacy Services
Revenue Optimization In Hospital Pharmacy Services Presenters: Kyle Skiermont, PharmD, COO, Fairview Pharmacy Services FACULTY DISCLOSURE The faculty reported the following financial relationships or relationships
More informationKatie Saul: Hello everyone. We're happy to have you all with us today. This is Katie Saul from the Title X Family Planning National Training Center.
Katie Saul: Hello everyone. We're happy to have you all with us today. This is Katie Saul from the Title X Family Planning National Training Center. I'm pleased to welcome you all to today's webinar, which
More informationMedicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Pennsylvania ehealth Initiative All Committee Meeting November 14, 2012
Medicare & Medicaid EHR Incentive Programs Stage 2 Final Rule Pennsylvania ehealth Initiative All Committee Meeting November 14, 2012 What is in the Rule Changes to Stage 1 of meaningful use Stage 2 of
More informationProvider Status in Pharmacy Practice What is it and Why do we want it?
Provider Status in Pharmacy Practice What is it and Why do we want it? Michael Jackson, BPharm, CPh Executive Vice President and CEO Florida Pharmacy Association jackson@pharmview.com 1 Disclosures I have
More informationPhysician/Industry Contacts: Updated Focus on CME & Grassley Looks at Possible Research Conflicts
Physician/Industry Contacts: Updated Focus on CME & Grassley Looks at Possible Research Conflicts AdvaMed Webinar // October 28, 2008 R. Michael Scarano, Jr. Heidi A. Sorensen Judith A. Waltz 10/20/2008
More information10/12/2017 COST REPORTING 201. October 18, Michael K. Westerfield, CPA, FHFMA Senior Manager
COST REPORTING 201 October 18, 2017 Michael K. Westerfield, CPA, FHFMA Senior Manager 1 AGENDA Cost Report 101 Review Wage Index Disproportionate Share S-10 Indirect Medical Education (IME) Graduate Medical
More information